Live Breaking News & Updates on Pat whitworth

Stay updated with breaking news from Pat whitworth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics

/PRNewswire/ -- Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat...

United-states , American , Andrew-wade , Pat-whitworth , Dan-forche , Chris-emery , Linkedin , Aptitude-health , Research-committee , University-of-louisville , National-cancer-institute , Prnewswire-prelude-corporation-preludedx

PreludeDx Presents Comparative Data Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT

Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores

Boston , Massachusetts , United-states , Dan-forche , Pat-whitworth , Johnb-hynes-veterans-memorial-convention-center , Prelude-corporation-preludedx , University-of-tennessee , University-of-california-san-francisco , Nashville-breast-center , National-cancer-institute , Prelude-corporation

PreludeDx™ Announces Latest Data on DCISionRT® in Multiple Presentations at the 2022 San Antonio Breast Cancer Symposium

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that...

Australia , Perth , Western-australia , United-states , San-antonio , Texas , Pat-whitworth , Dan-forche , Andrew-wade , Rachel-rabinovitch , Cory-dunn , Yvonne-zissiadis-jr

Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema

/PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce publication of a systematic literature review showing that early detection and intervention...

Australia , Brisbane , Queensland , Pat-whitworth , Digital-health-platform , Prnewswire-impedimed-limited , Nashville-breast-center , L-dex-found , Cost-effective , Practical-method , Monitor-breast-cancer-patients , Early-signs

Time for Universal Germline Genetic Testing in Breast Cancer

New data suggest that existing restrictive criteria for germline genetic testing for breast cancer deny patients data-informed clinical management.

New-york , United-states , Phoenix , Arizona , Tennessee , Nashville , Pat-whitworth , Julia-smith , Niloy-jewel-samadder , Nashville-breast-center , National-comprehensive-cancer-network , Langone-perlmutter-cancer-center

PreludeDx™ Presents New DCISionRT® Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced compelling...

Mccormick-place , Illinois , United-states , Chicago , American , Pat-whitworth , Dan-forche , Andrew-wade , Cory-dunn , Instagram , Linkedin , Prnewswire-prelude-corporation-preludedx

PreludeDx™ to Present DCIS Study Results Assessing Benefit of Adjuvant Endocrine Therapy Using DCISionRT® During Oral Presentation at ASCO 2022 Annual Meeting

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that...

Mccormick-place , Illinois , United-states , Chicago , American , Pat-whitworth , Dan-forche , Andrew-wade , Cory-dunn , Instagram , Linkedin , Prnewswire-prelude-corporation-preludedx

New shot blasting site at Combpyne approved by EDDC.

The site is on the hamlet between Colyton and Lyme Regis.

Lyme-regis , Dorset , United-kingdom , Colyton , Devon , Combpyne , Rousdon , Pat-whitworth , April-moore , Gail-beecroft , Mark-perry , Devon-district-council

PreludeDx™ to Present DCISionRT® and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that...

Australia , United-states , Pat-whitworth , G-bruce-mann , Andrew-wade , Cory-dunn , Frank-vicini , Instagram , Linkedin , Prnewswire-prelude-corporation-preludedx , National-cancer-institute , Nashville-breast-center

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today it...

San-antonio , Texas , United-states , Australia , Pat-whitworth , Dan-forche , Andrew-wade , Cory-dunn , Instagram , Linkedin , National-cancer-institute , Nashville-breast-center